These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1295397)

  • 21. [Interview with Gilbert Faure and Marie-Christine Béné: what is going to happen tomorrow in leukemia immunophenotyping?].
    Faure G; Béné MC
    Ann Med Interne (Paris); 1996; 147(6):408-10. PubMed ID: 9092344
    [No Abstract]   [Full Text] [Related]  

  • 22. Interview with Peter Lydyard. What is going to happen tomorrow as far as heat-shock proteins are concerned?
    Lydyard P
    Ann Med Interne (Paris); 1993; 144(2):97-8. PubMed ID: 8333667
    [No Abstract]   [Full Text] [Related]  

  • 23. Interview with Jean-Pierre Revillard. What is going to happen tomorrow as far as treatment of autoimmune disorders is concerned?
    Revillard JP
    Ann Med Interne (Paris); 1997; 148(1):11-4. PubMed ID: 9137693
    [No Abstract]   [Full Text] [Related]  

  • 24. Viruses and autoimmunity.
    Kim B; Kaistha SD; Rouse BT
    Autoimmunity; 2006 Feb; 39(1):71-7. PubMed ID: 16455584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viruses and autoimmunity.
    Kim B; Deshpande Kaistha S; Rouse BT
    Autoimmunity; 2005 Dec; 38(8):559-65. PubMed ID: 16390809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interview with Peter Lipsky. What is going to happen tomorrow as far as rheumatoid T and B cell subsets are concerned?
    Lipsky P
    Ann Med Interne (Paris); 1995; 146(2):111-3. PubMed ID: 7598334
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmune heart failure: new understandings of pathogenesis.
    Eriksson U; Penninger JM
    Int J Biochem Cell Biol; 2005 Jan; 37(1):27-32. PubMed ID: 15381145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is going to happen tomorrow in the field of anti-idiotype antibodies?
    Isenberg D
    Ann Med Interne (Paris); 1992; 143(2):113-4. PubMed ID: 1530218
    [No Abstract]   [Full Text] [Related]  

  • 29. Viruses and autoimmunity.
    East J
    Vox Sang; 1969 Apr; 16(4):318-24. PubMed ID: 4184410
    [No Abstract]   [Full Text] [Related]  

  • 30. [An interview with Bertrand Wechsler. What is going to happen in the field of Behçet disease?].
    Wechsler B
    Ann Med Interne (Paris); 1996; 147(2):99-101. PubMed ID: 8760687
    [No Abstract]   [Full Text] [Related]  

  • 31. Interview with Donato Alarcon-Segovia. What will happen tomorrow in the treatment of lupus?. Interview by Jean-Charles Piette.
    Alarcon-Segovia D
    Ann Med Interne (Paris); 1995; 146(6):397-8. PubMed ID: 8597336
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmunity and pathophysiology.
    Tsonis IA; Avrameas S; Moutsopoulos HM
    J Autoimmun; 2007 Dec; 29(4):203-5. PubMed ID: 17884336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An interview with Marcel-Francis Kahn. What is the future of mixed connective tissue diseases and Sharp syndrome?. Interview by P. Youinou].
    Kahn MF
    Ann Med Interne (Paris); 1993; 144(8):563-6. PubMed ID: 8179245
    [No Abstract]   [Full Text] [Related]  

  • 34. [An interview with René Hivon. What will happen tomorrow in medical education?].
    Jouquan J
    Ann Med Interne (Paris); 1996; 147(1):31-4. PubMed ID: 8763087
    [No Abstract]   [Full Text] [Related]  

  • 35. Infections and autoimmunity--friends or foes?
    Kivity S; Agmon-Levin N; Blank M; Shoenfeld Y
    Trends Immunol; 2009 Aug; 30(8):409-14. PubMed ID: 19643667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is going to happen tomorrow regarding the antiphospholipid syndrome? Jean-Charles Piette.
    Piette JC
    Ann Med Interne (Paris); 1995; 146(8):555-8. PubMed ID: 8734081
    [No Abstract]   [Full Text] [Related]  

  • 37. [What is the future of the physiopathology and treatment of diabetes?. Interview by P. Youinou].
    Bach JF
    Ann Med Interne (Paris); 1992; 143(1):23-5. PubMed ID: 1605457
    [No Abstract]   [Full Text] [Related]  

  • 38. [Conversation with Jean-Louis Preud'homme. What is going to happen tomorrow with subpopulations of IGG (dosage, deficit, significance)].
    Preud'homme JL
    Ann Med Interne (Paris); 1992; 143(5):319-21. PubMed ID: 1482034
    [No Abstract]   [Full Text] [Related]  

  • 39. [New evidence of the antigenic relation between the viruses of epidemic neuropathy and the human nervous system. A study of the immune cellular response in patients with epidemic neuropathy and controls. A review of the topic].
    Sierra Vázquez B; Más Lago P; Pérez AB; Sarmiento Pérez L; Bello Corredor M; Avalos Redón I; Resik Aguirre S; Denny T; Gissel García ; Guzmán Tirado MG
    Rev Cubana Med Trop; 1998; 50 Suppl():249-53. PubMed ID: 10349456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serological markers of viral infections in patients with rheumatoid arthritis].
    Kurbanov SA; Mamedov MK
    Georgian Med News; 2009 Jan; (166):65-7. PubMed ID: 19202223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.